Search Results - "Berry, Darcy K"

FANCD2 Mutation in a Patient With Early Rectal Cancer Receiving Definitive Chemoradiation by McDonald, Jordan, Chuang, Chine-Yu, Hicks, J. Kevin, Berry, Darcy K., Imanirad, Iman, Rishi, Anupam, Frakes, Jessica M., Hoffe, Sarah E., Felder, Seth

Get full text

Breaking Down the Barriers of Hereditary Cancer Risk Disclosure in AYA by Moore, Colin, Berry, Darcy K., Gewandter, Kathleen R.

Get full text

Revising the FOCUS framework through a qualitative study assessing self‐reported counseling skills of genetic counselors by Zale, Abigail, Zierhut, Heather, Dean, Marleah, Berry, Darcy K., Racobaldo, Melissa, Cragun, Deborah

“…Frameworks have been developed to help conceptualize clinical genetic counseling (GC), and observational studies have helped understand the process and content…”
Get full text

Six case reports of NTHL1‐associated tumor syndrome further support it as a multi‐tumor predisposition syndrome by Weatherill, Chelsey B., Burke, Sarah A., Haskins, Carolyn G., Berry, Darcy K., Homer, Jeanne P., Demeure, Michael J., Darabi, Sourat

“…NTHL1‐associated tumor syndrome (NATS) is an autosomal recessive condition characterized by an increased risk for colorectal polyposis and colorectal cancer…”
Get full text

Interpretation of ambiguous TP53 test results: Mosaicism, clonal hematopoiesis, and variants of uncertain significance by Berry, Darcy K., Gillis, Nancy, Padron, Eric, Moore, Colin, Barton, Laura V., Gewandter, Kathleen R., Haskins, Carolyn G., Knepper, Todd C.

“…The increased use of next‐generation sequencing has led to the detection of pathogenic TP53 variants in the germline setting in patients without a personal or…”
Get full text

PARP Inhibitors in Pancreatic Cancer with Homologous Recombination Repair Gene Mutations: A Single-Institution Experience by Miao, Ruoyu, Blue, Kirsten, Sommerer, Katelyn, Shah, Anand, Bottiglieri, Sal, Del Cueto, Alex, Berry, Darcy K, Ho, Teresa T, Hicks, James Kevin, Kim, Dae Won

“…Limited data are available regarding the anticancer activity of PARP inhibitors (PARPis) in pancreatic cancer with mutations in HRR genes other than and . We…”
Get full text